Viewing Study NCT05800366


Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2026-01-27 @ 7:22 AM
Study NCT ID: NCT05800366
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-14
First Post: 2023-03-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
Sponsor: Jennifer Crombie, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module